Dren Bio
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
384 Foster City Blvd, Foster City, Calif...Phone Number
(415) 737-5277Website
www.drenbio.comRevenue
$10.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Dren Bio
Dren Bio is a California based biotechnology company developing powerful protein engineering technologies to deplete cells, protein aggregates and other disease-causing agents. Dren's lead programs are initially focused on hematologic neoplasms and solid cancers. Dren is actively working in other areas including auto-immune disorders and diseases of protein aggregation. Dren's team includes accomplished research and development personnel with strong collective industry experience.Explore more
Dren Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Dren Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Dren Bio had a recent Job posting/layoffs
Dren Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Dren Bio launches new products
Funding: Get notified immidiatlly once Dren Bio has new funding data
Earning: See what the market has to say on Dren Bio recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Dren Bio
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Dren Bio has recently received funding, and reach out quickly before it becomes old news!
Check out if Dren Bio is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Dren Bio as Masked Content
Find 3 more new buyers
Compare Similar Companies to Dren Bio
Compare insights from companies similar to Dren Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Dren Bio
$10.6M
11-50
Private
$65M
2019
SV
Sridhar ViswanathanExecutive VP, Process Sciences & Manufacturing Operations
$7.7M
11-50
Public
$340.5M
2015
KB
Kristi BalacyHead Senior Director, Clinical Development Operations & of Clinical Operations
Company Profile Activity
Activity Insights
Dren Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Dren Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Dren Bio.
Dren Bio financials insights
Gather financial insights about Dren Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series B
$65M
Dren Bio Tech Stack
A closer look at the technologies used by Dren Bio
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Facilities Relocation / Expansion
Dren Bio is planning to move offices in December 2025. The move will impact approximately 30 employees at the existing office located at 384 Foster City Blvd, Foster City, CA.
Facilities Relocation/Expansion
Hiring Plans
Hiring Plans
Dren Bio News & Media
Press Release: Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline
Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipelineDren Bio Announces Strategic Collaboration with Novartis to Develop Novel Targeted Myeloid Engagers for Cancer
FOSTER CITY, Calif.--(BUSINESS WIRE)--Dren Bio Announces Strategic Collaboration with Novartis to Develop Novel Targeted Myeloid Engagers for CancerDren Bio Strengthens Leadership Team with Appointment of Amit Mehta, Ph.D., as Chief Operating Officer and Chief Business Officer
FOSTER CITY, Calif.--(BUSINESS WIRE)--Dren Bio Strengthens Leadership Team with Appointment of Amit Mehta, Ph.D., as Chief Operating Officer and Chief Business OfficerLarge Granular Lymphocyte Leukemia Market is Projected to Grow During the Study Period (2019-2032), Assesses DelveInsight | Key Companies - Bristol Myers Squibb, Innate Pharma, Kymera Therapeutics, EUSA Pharma, Abcuro, Dren Bio, Novotech
According to DelveInsight's' estimates, the Large Granular Lymphocyte Leukemia market in the 7MM is expected to show positive growth, during the forecast period (2023–2032), mainly attributed to the launch of upcoming therapies and the increasing prevalence of Large Granular Lymphocyte...
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Dren Bio
Sign Up For FreeTo access detailed company insights
Dren Bio is a California based biotechnology company developing powerful protein engineering technologies to deplete cells, protein aggregates and other disease-causing agents. Dren's lead programs are initially focused on hematologic neoplasms and solid cancers. Dren is actively working in other areas including auto-immune disorders and diseases o... Read More
